About Kairos Pharma
Kairos Pharma is a private company based in Los Angeles, California. It has reported $675,000 raised in one offering on Form D since April 2023. Its chief executive is John Yu.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2022 | Apr 27, 2023 | $675,000of $3.0M target | 9 | $75,000 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kairos Pharma's Form D filed Apr 27, 2023.
JY
John Yu
Chief Executive Officer and Chairman
NB
Neil Bhowmick
Chief Scientific Officer
RM
Ramachandran Murali
Vice President of Research and Development
DS
Doug Samuelson
Chief Financial Officer
HB
Hyun Bae
Independent Director